CITADEL ADVISORS LLC

Position in NRXP — NRX Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL

Back to NRXP Full portfolio

Position in NRXP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,781,375

+$2,781,375 QoQ

Shares Held

680,043

Ownership

1.57%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 47 holders

Holding Since

Sep 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRXP Over Time

Shares Held

Position Value (USD)

Derivatives in NRXP

reported options exposure · as of Jun 30, 2026

CallValue

$916,978

CallShares

224,200

PutValue

$109,203

PutShares

26,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. NRXP ranks #183 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

All Filings in NRXP

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$916,978	224,200	+807.7%	Call	Defined	2026-08-14
2026-06-30	$109,203	26,700	+926.9%	Put	Defined	2026-08-14
2026-06-30	$2,781,375	680,043	+636.3%	Shares	Defined	2026-08-14
2026-03-31	$52,611	24,700	-31.0%	Call	Defined	2026-05-15
2025-12-31	$97,018	35,800	+8.8%	Call	Defined	2026-02-17
2025-09-30	$108,570	32,900	+67.9%	Call	Defined	2025-11-14
2025-06-30	$301,096	92,361	+37293.1%	Shares	Defined	2025-08-14
2024-12-31	$5,720	2,600	+160.0%	Put	Defined	2025-02-14
2024-12-31	$43,120	19,600	-44.5%	Call	Defined	2025-02-14
2024-09-30	$1,690	1,000	+17.6%	Put	Defined	2024-11-14
2024-09-30	$59,657	35,300	+57.5%	Call	Defined	2024-11-14
2024-06-30	$54,680	22,410	-27.5%	Call	Defined	2024-08-14
2024-06-30	$2,074	850	-91.1%	Put	Defined	2024-08-14
2024-03-31	$14,584	30,900	-64.9%	Call	Defined	2024-05-15
2024-03-31	$4,531	9,600	+966.7%	Put	Defined	2024-05-15
2023-12-31	$40,480	88,000	-6.0%	Call	Defined	2024-02-14
2023-12-31	$414	900	-79.1%	Put	Defined	2024-02-14
2023-09-30	$24,336	93,600	+6.7%	Call	Defined	2023-11-14
2023-09-30	$1,118	4,300	-4.4%	Put	Defined	2023-11-14
2023-06-30	$2,178	4,500	-59.5%	Put	Defined	2023-08-14
2023-06-30	$119	247	0.0%	Shares	Defined	2023-08-14
2023-06-30	$42,446	87,700	-0.7%	Call	Defined	2023-08-14
2023-03-31	$162	247	-98.0%	Shares	Defined	2023-05-15
2023-03-31	$7,314	11,100	+30.6%	Put	Defined	2023-05-15
2023-03-31	$58,189	88,300	-46.5%	Call	Defined	2023-05-15
2022-12-31	$13,937	12,556	-86.3%	Shares	Defined	2023-02-14
2022-12-31	$9,435	8,500	-65.3%	Put	Defined	2023-02-14
2022-12-31	$183,372	165,200	-15.7%	Call	Defined	2023-02-14
2022-09-30	$18,130	24,500	-23.7%	Put	Defined	2022-11-14
2022-09-30	$145,040	196,000	-12.0%	Call	Defined	2022-11-14
2022-06-30	$133,620	222,700	-23.4%	Call	Defined	2022-08-15
2022-06-30	$54,999	91,666	-32.1%	Shares	Defined	2022-08-15
2022-06-30	$19,260	32,100	-57.2%	Put	Defined	2022-08-15
2022-03-31	$712,460	290,800	+0.8%	Call	Defined	2022-05-16
2022-03-31	$183,750	75,000	-61.8%	Put	Defined	2022-05-16
2021-12-31	$938,314	196,300	-47.5%	Put	Defined	2022-02-14
2021-12-31	$1,378,552	288,400	+705.6%	Call	Defined	2022-02-14
2021-09-30	$331,866	35,800	—	Call	Defined	2021-11-15
2021-09-30	$1,252,256	135,087	—	Shares	Defined	2021-11-15
2021-09-30	$3,466,980	374,000	—	Put	Defined	2021-11-15
No filing history on record for this holder in this stock.